Van Lanschot Kempen Investment Management N.V. Sells 118,615 Shares of Henry Schein, Inc. $HSIC

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Van Lanschot Kempen Investment Management N.V. decreased its holdings in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 14.4% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 705,213 shares of the company's stock after selling 118,615 shares during the period. Van Lanschot Kempen Investment Management N.V. owned 0.58% of Henry Schein worth $48,300,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. Investment Management Corp VA ADV bought a new position in Henry Schein during the fourth quarter valued at approximately $32,000. Rakuten Securities Inc. bought a new position in Henry Schein during the first quarter valued at approximately $34,000. Whittier Trust Co. boosted its stake in Henry Schein by 714.3% during the first quarter. Whittier Trust Co. now owns 798 shares of the company's stock valued at $55,000 after buying an additional 700 shares during the last quarter. UMB Bank n.a. boosted its stake in Henry Schein by 23.2% during the first quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock valued at $73,000 after buying an additional 201 shares during the last quarter. Finally, Allworth Financial LP boosted its stake in Henry Schein by 24.5% during the first quarter. Allworth Financial LP now owns 1,178 shares of the company's stock valued at $78,000 after buying an additional 232 shares during the last quarter. Institutional investors own 96.62% of the company's stock.

Henry Schein Trading Down 0.9%

Shares of HSIC stock opened at $67.22 on Tuesday. Henry Schein, Inc. has a 1 year low of $60.56 and a 1 year high of $82.49. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.41 and a quick ratio of 0.78. The stock's 50 day simple moving average is $70.73 and its two-hundred day simple moving average is $70.63. The company has a market cap of $8.15 billion, a PE ratio of 21.68, a price-to-earnings-growth ratio of 2.24 and a beta of 0.81.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $1.10 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.19 by ($0.09). Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The company had revenue of $3.24 billion for the quarter, compared to analysts' expectations of $3.22 billion. During the same quarter last year, the company earned $1.23 earnings per share. The company's revenue for the quarter was up 3.3% on a year-over-year basis. Research analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on HSIC. Barrington Research dropped their price target on Henry Schein from $86.00 to $78.00 and set an "outperform" rating for the company in a research note on Wednesday, August 6th. Robert W. Baird reissued a "neutral" rating and set a $72.00 price target (down from $82.00) on shares of Henry Schein in a research note on Monday, July 14th. Baird R W lowered Henry Schein from a "strong-buy" rating to a "hold" rating in a research note on Monday, July 14th. Piper Sandler dropped their price target on Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a research note on Wednesday, April 30th. Finally, JPMorgan Chase & Co. dropped their price target on Henry Schein from $80.00 to $76.00 and set an "overweight" rating for the company in a research note on Thursday, August 7th. Nine investment analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. According to MarketBeat, Henry Schein currently has an average rating of "Hold" and a consensus target price of $75.58.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.